http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006050365-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f3ed93dc35dfd405d2c60a12bb27394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1bf5e0e5dc60e898f210e0193d5a140
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B25-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B25-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B25-32
filingDate 2005-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57349496c02022995b40f9d5a57591cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5867eff8f17106c95c4232a467673fd
publicationDate 2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006050365-A3
titleOfInvention Methods for production of synthetic hydroxyapatite nanorods
abstract Disclosed herein are methods directed toward the synthesis of ordered structures of hydroxyapatite and hydroxyapatite derivatives. More specifically, disclosed herein is a method of preparing ordered hydroxyapatite nanorod structures including the steps of suspending calcium and phosphate in a solvent, adjusting the pH to above 5, and heating to a temperature sufficient to support formation of the ordered hydroxyapatite nanorod structures. In some cases, the methods may include ethylenediamine tetraacetic acid or ethylenediamine tetraacetic acid derivatives. Also disclosed are methods that additionally involve a step of coating hydroxyapatite nanorods with a protein or an amphiphile such as a surfactant or polymer.
priorityDate 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59207818-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003219466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6146686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5486365-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5652056-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448869297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21583932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061

Total number of triples: 29.